| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $12.01B | -7.2% |
| R&D Expense | $33.0M | -2.9% |
| SG&A Expense | $582.0M | +4.7% |
| Operating Income | $1.27B | -5.0% |
| Interest Expense | $436.0M | +53.5% |
| Pre-tax Income | $795.0M | -24.7% |
| Income Tax | $222.0M | -8.6% |
| Net Income | $450.0M | -38.1% |
| EPS (Basic) | $3.77 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.31B | +138.2% |
| Accounts Receivable | $1.09B | -1.5% |
| Inventory | $1.61B | -19.9% |
| Current Assets | $4.83B | +3.7% |
| Total Assets | $15.03B | +5.1% |
| Current Liabilities | $4.20B | +6.8% |
| Long-term Debt | $7.46B | +8.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.45B | +80.9% |
| Capital Expenditures | $793.0M | -5.5% |
| Investing Cash Flow | -$804.0M | -25.2% |
| Financing Cash Flow | $116.0M | +564.0% |
| Free Cash Flow | $660.0M | +1933.3% |
| -37.3% |
| EPS (Diluted) | $3.76 | -37.2% |
| Stockholders' Equity |
| $2.41B |
| +30.3% |